An interventional study of Lumoral Treatment and Standard oral hygiene instructions in Peri-Implantitis and Plaque, Dental, sponsored by Koite Health Oy. Recruiting at 1 site in Sweden. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-08-07.
Sponsored by Koite Health Oy · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Peri-Implantitis with a site in Sweden — 5 open to participants now, 6 under way, none of them phase 3. Peri-Implantitis · Sweden.
Among the 21 studies in Peri-Implantitis with a site in Sweden, this one is the 4th largest by planned enrollment of the 12 interventional ones that give a count, is one of 2 that started in 2024, is one of 8 with no phase, and was the 17th registered.
324 studies on the registry are indexed under Peri-Implantitis; 89 are open to participants now.
Browse Peri-Implantitis studies →5 of the 21 studies in Peri-Implantitis with a site in Sweden are open now. Recruiting first, the newest first:
Karolinska Institutet · Sites in Sweden
Ages 18+
Malmö University · Sites in Sweden, Austria
Ages 18–130
Kristianstad University · Sites in Sweden
Göteborg University · Sites in Sweden
Ages 18+
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 50 Peri-Implantitis studies recruiting now, 28 (56%) set no upper age limit and 9 (18%) stop at 75 or younger; 7 take children under 18; 26 take healthy volunteers.
This study: 18 Years to 85 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 2 started in 2024.
This study's planned enrollment of 80 is above the median of 40 across 196 interventional studies indexed under Peri-Implantitis.
Median enrollment 74 across the 12 interventional studies, 41 across the 9 observational. Of the 14 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 21 have an industry lead sponsor. The 10 most frequent:
Koite Health Oy is the lead sponsor of 14 studies on the registry; 3 are open to participants now.
Koite Health Oy has 1 study filed under Peri-Implantitis — fewer than ten, so there is no comparison to draw.
3 of the studies in Peri-Implantitis with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04847648Göteborg UniversityAir-polishing in the Treatment of Peri-implantitis | 2026-12-15 |
| NCT06648564Kristianstad University20-25 Year Follow-Up on Regenerative Bone Procedures for Peri-Implantitis | 2026-12-31 |
| NCT06017817Koite Health OyAntibacterial Photodynamic Therapy in the Management of Peri-implantitis | 2026-12-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 21 studies in Peri-Implantitis with a site in Sweden, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This early-stage study is designed to determine the efficacy of the Lumoral method in periimplantitis. Improved supragingival plaque control can help to also sustain subgingival plaque management in the long term. In addition, the device might have a photobiomodulation effect on periodontal tissues, thus impacting osseointegration.
Clinical signs of inflammation in peri-implantitis include bleeding on probing, suppuration, increased probing depth, and radiographic signs of bone loss. Currently, the best treatment options for peri-implantitis include non-surgical methods of biofilm removal in the supra-mucosal area around implants, and comprehensive guidance on self-performed infection control procedures. With more advanced peri-implantitis, anti-infective surgical treatment protocol would be needed.
Matrix metalloproteinase 8 (MMP-8) has been found to be elevated in association with oral infections, such as periodontitis and peri-implantitis. The level of active MMP-8 (aMMP-8) can detect to determine tissue health and to assess inflammation, and can easily be measured during a regular dental appointment with a chairside test.
The Lumoral Treatment is a CE-marked medical device developed to provide a potent, targeted antibacterial action on dental plaque in a home environment. The method mechanism of action is antibacterial photodynamic therapy (aPDT). The method is used by swishing a mouth rinse, which has a strong adherence to dental plaque. The plaque-adhered photoactive mouth rinse can be activated by a simple-to-use light applicator. Preliminary results have shown a promising anti-inflammatory response in addition to plaque reduction.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Lumoral Treatment; Standard, non-surgical anti-infective treatment by scaling and root planing (SRP); and Standard oral hygiene instructions for electric toothbrushing, interdental brush, and dental floss use.
Device: Lumoral Treatment · Procedure: Standard oral hygiene instructions · Procedure: Scaling and root planing (SRP
Standard, non-surgical anti-infective treatment by scaling and root planing (SRP); and Standard oral hygiene instructions for electric toothbrushing, interdental brush, and dental floss use.
Procedure: Standard oral hygiene instructions · Procedure: Scaling and root planing (SRP
Lumoral Treatment; Surgical anti-infective peri-implantitis treatment; and Standard oral hygiene instructions for electric toothbrushing, interdental brush, and dental floss use.
Device: Lumoral Treatment · Procedure: Standard oral hygiene instructions · Procedure: surgical anti-infective peri-implantitis treatment
Surgical anti-infective peri-implantitis treatment; and Standard oral hygiene instructions for electric toothbrushing, interdental brush, and dental floss use.
Procedure: Standard oral hygiene instructions · Procedure: surgical anti-infective peri-implantitis treatment
Anti-infective photodynamic therapy for plaque-induced oral conditions
Standard oral hygiene instructions for electric toothbrushing, interdental brush, and dental floss use
non-surgical anti-infective treatment by scaling and root planing
surgical anti-infective peri-implantitis treatment
Bleeding on probing (BOP)
Change in the inflammatory parameter BOP. A full-mouth assessment at six sites per tooth: * Gingival bleeding is considered as positive if bleeding occurs within 15 seconds after gentle probing with a probe at the sulcus * Dichotomous scoring to each site of the tooth as bleeding "1 present" and "0 absent" * BOP reported as the percentage (%) of sites with positive findings * Calculation formula: number of bleeding sites/ 6 times number of teeth
Time frame: 6 months
Active matrix metalloproteinase 8 (aMMP-8)
The oral rinse fluid sample collection and the aMMP-8 marker analysis will be performed using Periosafe test (Dentognostics GmbH) according to the manufacturer's instructions.
Time frame: 6 months
Inflammatory marker total MMP-8 analysis
Measurement of pro and active MMP-8. Units: ng/ml.
Time frame: 6 months
Inflammatory marker total MMP-9 analysis
Measurement of pro and active MMP-9. Units: ng/ml.
Time frame: 6 months
Inflammatory marker total MMP-2 analysis
Measurement of pro and active MMP-2. Units: ng/ml.
Time frame: 6 months
Inflammatory marker total TIMP analysis
Units: ng/ml.
Time frame: 6 months
Interleukins analysis
Units: pg/ml.
Time frame: 6 months
Total calprotectin analysis
Salivary calprotectin. Units: microgram/ml.
Time frame: 6 months
Peridontal Pocket Depth (PPD)
A full-mouth assessment, measured at six sites per tooth. Assessed from the base of the pocket to the gingival margin (mm)
Time frame: 6 months
Visual Plaque Index( VPI)
Assessment of six index teeth, measured at four sites per tooth * Dichotomous scoring to each site of the tooth as plaque "1 present" and "0 absent" * VPI reported as the percentage (%) of sites with plaque * Calculation formula: number of sites with plaque/ 4 times number of teeth
Time frame: 6 months
Clinical Attachment Level (CAL)
A full-mouth assessment, measured at six sites per tooth \- Assessed as the distance from the cementoenamel junction (CEJ) to the bottom of the periodontal pocket (mm) The measurements to calculate CAL: * distance from the gingival margin to the CEJ and PPD * in recession: PPD + gingival margin to the CEJ * in tissue overgrowth: PPD - gingival margin to the CEJ
Time frame: 6 months
Bacterial flora
Quantification of periodontopathic bacteria by 16S rRNA sequencing analysis \- Microbiological samples can be collected using Iso Taper Paper Points, size-20 (VDW GmbH) from selected gingival/periodontal pockets with maximum initial probing depth. The paper points can be placed into sterile, small-aliquot containers, and immediately stored at -20°C until analysis
Time frame: 6 Months
Adverse events
Any suspicion of an adverse event related to the investigational device, the treatment method, or the study protocol.
Time frame: 6 months
OHIP-14 questionnaire
\- Measures people's perception of the social impact of oral disorders on their well-being. Fourteen items of OHIP are divided into seven dimensions: functional limitation, physical discomfort, psychological discomfort, physical disability, psychological disability, social disability, and handicaps. (Slade GD 1997). Responses are made on a 5-point scale (from 0 = never, to 4 = very often).
Time frame: 6 months
Mobility assessment
Manual assessment of the template movement, mobility testing sideways, and up and down \- Scoring in numbers 0 - 3
Time frame: 6 months
Suppuration index
\- Visual assessment of the amount of pus, scoring: 0: No suppuration or exudate present 1. Minimal suppuration or exudate present 2. Moderate suppuration or exudate present 3. Severe suppuration or exudate present
Time frame: 6 months
Plan to share: No
Started May 2024 (actual). Primary completion is estimated for Dec 2026, 31 months after the start.
Of 128 interventional studies with no phase under Peri-Implantitis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 40. This study's planned 31 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Koite Health Oy